Alnylam Pharmaceuticals (ALNY) EBIT (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) reported EBIT of $231.44 million for Q2 2026, compared with -$16.2 million a year earlier and down 13.8% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) EBIT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alnylam Pharmaceuticals' EBIT came in at $999.78 million; for FY2025, it came in at $501.58 million.
- By year, EBIT came in at -$176.89 million in FY2024, -$282.18 million in FY2023, -$785.07 million in FY2022 and -$708.65 million in FY2021.
- Five-year quarterly EBIT spans a low of -$258.04 million in Q3 2022 and a high of $367.98 million in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $268.64 million (Q1 2026), $131.72 million (Q4 2025) and $367.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.65 Bn | 1,129.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 633.19 Bn | 551.72 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.90 Bn | 475.01 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 377.07 Bn | 331.45 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 302.35 Bn | 266.34 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 240.68 Bn | 196.07 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.20 Bn | 167.40 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Alnylam Pharmaceuticals | 30.42 Bn | 18.47 Bn | 992.69 Mn | 231.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231.44 Mn |
| Mar 31, 2026 | 268.64 Mn |
| Dec 31, 2025 | 131.72 Mn |
| Sep 30, 2025 | 367.98 Mn |
| Jun 30, 2025 | -16.20 Mn |
| Mar 31, 2025 | 18.08 Mn |
| Dec 31, 2024 | -105.16 Mn |
| Sep 30, 2024 | -76.91 Mn |
| Jun 30, 2024 | 48.61 Mn |
| Mar 31, 2024 | -43.44 Mn |
| Dec 31, 2023 | -116.40 Mn |
| Sep 30, 2023 | 213.87 Mn |
| Jun 30, 2023 | -229.83 Mn |
| Mar 31, 2023 | -149.81 Mn |
| Dec 31, 2022 | -188.61 Mn |
| Sep 30, 2022 | -258.04 Mn |
| Jun 30, 2022 | -191.69 Mn |
| Mar 31, 2022 | -146.73 Mn |
| Dec 31, 2021 | -194.56 Mn |
| Sep 30, 2021 | -181.68 Mn |
API Access
Alnylam Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();